YD Bio Limited (YDES)
$6.10-3.63%Close
BUYCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $432M
- Beta
- -0.12
- P/E (TTM)
- -50.83
- Short % float
- 12.43%
- Days to cover
- 1.0
- SI change
- +312.8%
- 1W
- -0.81%
- 1M
- +59.27%
- vs SPY 1W
- -0.67%
- vs SPY 1M
- +56.76%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on YDES?
- LOPJLB’s latest quantitative signal on YD Bio Limited Ordinary Shares (YDES) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is YDES in?
- YD Bio Limited Ordinary Shares (YDES) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does YD Bio Limited Ordinary Shares (YDES) do?
- YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic so…